Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016

ConclusionsPrior use of cephalosporin or BLBLI combination antibiotics increased the risk ratio forESBL-producingE. coli infection. Hypoproteinemia and severe disease are independent risk factors for death in patients withE. coli BSIs. There was no significant difference in the 28  day prognosis of patients with ESBL-producingE. coli and those with non-ESBL-producingE. coli BSIs. These data do not support the conclusion that carbapenems might be more effective than BLBLI antibiotics for treatment of patients with BSIs caused by ESBL-producingE. coli.
Source: Antimicrobial Resistance and Infection Control - Category: Infectious Diseases Source Type: research